Share Price

SEQUANA MEDICAL

ISIN: XXXXXXXXXXXXX-XXXX Updated at 11:05:33

EURO 22.40

XXXXX.XX

+2.18%

For more information, please consult Euronext

Prev close
21.84

Open
20.60

Volume
17578

Lowest price
10.10

Highest price
20.20

Bid price
20.60

Ask price
20.60

Trading sessions
200

Capitalization
246.01M

Share Data

Status as of 11 February 2019

  • Outstanding share capital: EUR 1,306,939.52
  • Outstanding voting securities: 12,611,900 shares
  • Outstanding voting rights (“denominator”): 12,611,900 voting rights
  • Voting securities that can still be issued: 1,912,971 shares (each share entailing one voting right)
Major Shareholdings
Last update: 22 February 2019

Overview of major shareholdings

This graph represents Sequana Medical’s major shareholders, based on transparency notifications received by the Company, to date.

Overview of transparency notifications received to date

The Belgian Transparency Act refers to article 14 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings in issuers shares of which are admitted to trading on a regulated market and laying down miscellaneous provision.
Pursuant to this Belgian Transparency Act and the articles of association of the Company, a notification to the Company and the Belgian Financial Services and Markets Authority (FSMA) is required by all natural and legal persons in each case where the percentage of voting rights attached to the securities held by such persons in the Company reaches, exceeds or falls below the threshold of 3%, 5%, 10%, and every subsequent multiple of 5%, of the total number of voting rights in the Company.

For more information and the appropriate transparency forms, please contact Sequana Medical Investor Relations (ir@sequanamedical.com) or the FSMA.

Shareholder Date of notification Transparency notification Press release
Newton Biocapital I Pricav Privée SA 21-Feb-2019 Download pdf 25-Feb-2019
Venture Incubator AG / VI Partners AG 21-Feb-2019 Download pdf 25-Feb-2019
NeoMed IV Extension L.P. / NeoMed Innovation V L.P. 20-Feb-2019 Download pdf 25-Feb-2019
LSP Health Economics Fund Management B.V. 19-Feb-2019 Download pdf 25-Feb-2019
Federale Participatie- en Investeringsmaatschappij N.V. 18-Feb-2019 Download pdf 25-Feb-2019
Participatiemaatschappij Vlaanderen NV 18-Feb-2019 Download pdf 25-Feb-2019
Capricorn Health-tech Fund NV / Quest for Growth NV 18-Feb-2019 Download pdf 25-Feb-2019
Analyst Coverage
KBC Securities

Lenny Van Steenhuyse & Sandra Cauwenberghs


Kempen

Alex Cogut & Ingrid Gafanhao


Mirabaud

Daniel Jelovcan

Any opinions, estimates or forecasts regarding Sequana Medical’s performance made by these analysts are those of the author and do not reflect the views of Sequana Medical and its management. Sequana Medical does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
To obtain a copy of their research reports, please contact their respective institutions.

Shareholder Meetings

APRIL 25, 2019

Extraordinary General Meeting

Invitation

Explanatory Note

Proxy Form EN / Proxy Form NL (please complete the Dutch form)

Vote by Mail Form EN / Vote by Mail Form NL (please complete the Dutch form)

Outstanding Shares and Voting Rights

Attendance Form EN / Attendance Form NL (please complete the Dutch form)


MAY 23, 2019

Annual General Meeting

We would like to use cookies to better understand your use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our
Privacy & Cookie Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close